Noticias del mercado de valores
Últimas noticias financieras · Actualizado Jul 24, 2026
AMD Alcanza un Máximo Histórico -- ¿Es Demasiado Tarde Para Comprar?
AMD Just Hit an All-Time High -- Is it Too Late to Buy?
The panel discusses AMD's record-breaking quarter, with concerns around valuation, supply chain constraints, and demand visibility. The key debate revolves …
Acuta Capital apuesta por Erasca (ERAS) y tratamientos oncológicos dirigidos con una compra de 354.575 acciones
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
Despite Acuta Capital's significant investment, the panel is largely bearish due to ERAS-0015 trial's patient death, high cash burn rate, …
¿Es Kailera Therapeutics una compra después de su exitosa salida a bolsa?
Is Kailera Therapeutics a Buy After Its Sizzling IPO?
Kailera Therapeutics' IPO is considered high-risk due to intense competition, lack of approved products, and substantial clinical and regulatory risks. …
¿Es LegalZoom Stock una Compra Después de que el CEO Comprara 125,000 Acciones?
Is LegalZoom Stock a Buy After the CEO Purchased 125,000 Shares?
Despite a CEO buy signal, the panel is largely bearish due to LegalZoom's eroding moat from AI disruption, anemic margins, …
Greg Abel Está Comprando Acciones de la Que Probablemente Sea la Acción Favorita de Warren Buffett. ¿Deberías Comprarla Tú También?
Greg Abel Is Buying Shares of What Is Probably Warren Buffett's Favorite Stock. Should You Buy It Too?
Panelists generally agree that Berkshire Hathaway's current cash hoard and buyback activity signal a defensive posture rather than a growth …
Patient Square Realiza una Gran Apuesta en Nektar Pharmaceuticals (NKTR) Comprando 210,000 Acciones
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares
Panelists generally agree that Patient Square's investment in NKTR signals confidence in Rezolve-AD's Phase 2b results, but they caution about …
Warren Buffett Ha Estado Diciendo Esto Durante Años. 1 ETF de Vanguard Pone Ese Consejo en Práctica.
Warren Buffett Has Been Saying This for Years. 1 Vanguard ETF Puts That Advice Into Practice.
The panel agrees that VOO's high tech concentration (33%) poses significant risk, with potential for amplified volatility during corrections. They …
Ipsen: Los datos de Corabotasa demuestran una eficacia rápida y duradera en las líneas glabelares
Ipsen : Corabotase Data Demonstrate Rapid, Durable Efficacy In Glabellar Lines
Ipsen's corabotase shows promising Phase II data with rapid onset and strong 24-week durability versus Dysport, but Phase III results …
¿Las acciones de WaterBridge son una compra después de que Ranger Investment aumentara su participación en 345.000 acciones?
Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares?
Despite Gemini's 'regulatory moat' argument, the panel consensus is bearish due to WaterBridge's high debt, lack of consistent profitability, and …
Lime Presentó una Oferta Pública Inicial -- Compre Esta Acción en su Lugar
Lime Filed for an IPO -- Buy This Stock Instead
The panel consensus is bearish on Lime's IPO, citing the 'going concern' warning, Lime's debt maturity, and the risk of …
NVent Electric Board Aprueba Programa de Recompra de Acciones por $500 Millones
NVent Electric Board Approves $500 Mln Share Repurchase Program
The panel is neutral on NVT's $500M, 3-year buyback program. While the program is shareholder-friendly, the delayed start and lack …
Tu Beneficio de Seguro Social Podría Ser Menor de lo Que Esperas si Ignoras Esta Regla
Your Social Security Benefit Could Be Smaller Than You Expect if You Ignore This Rule
The panel discusses the Social Security earnings test, highlighting its immediate liquidity crisis for lower-income retirees and the double penalty …